Drugs / Sc610 cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05633589 | Dec 2022 → May 2024 | malignant urinary system neoplasm | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sc610 cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05633589 ↗ |
| Modality | Cell therapy | “cell therapy designed to observe and evaluate” NCT05633589 ↗ |
| Route | Intravenous | “The obtained Sc610 is used for one-time intravenous infusion.” NCT05633589 ↗ |